Results 171 to 180 of about 26,507,570 (297)

Real-time measurements of the nucleation, growth and dissociation of single Rad51–DNA nucleoprotein filaments [PDF]

open access: gold, 2007
Judith Miné   +5 more
openalex   +1 more source

A framework for real-time image detection of bioaerosols. [PDF]

open access: yesSci Rep
Juidici RA   +5 more
europepmc   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

open access: yesMolecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li   +10 more
wiley   +1 more source

Real-Time MRI With Deep Learning for Efficient Evaluation of Neuromuscular Breathing Impairment. [PDF]

open access: yesMedComm (2020)
Zeng R   +13 more
europepmc   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

open access: yesMolecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff   +11 more
wiley   +1 more source

RTP: A Transport Protocol for Real-Time Applications

open access: yesRequest for Comments, 1996
H. Schulzrinne   +3 more
semanticscholar   +1 more source

Interpretable machine learning-based real-time sepsis diagnosis. [PDF]

open access: yesSci Rep
Mahmud F   +4 more
europepmc   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy